- Report analyzes biotech clusters and funding
Chicago, Denver, Houston, Indianapolis and Atlanta, as well as Florida, are challenging established biotechnology hubs such as Minneapolis, Seattle and the Research Triangle area of North Carolina, according to a report from real estate firm Jones Lang LaSalle. States competing for biotech companies are offering tax incentives and funding research accelerators. Consolidation in the biotech and pharmaceutical industries will feed activity in established clusters in the short term, but emerging hubs are likely to enjoy increased activity in the longer term, Alex Philippidis writes. Genetic Engineering & Biotechnology News (1/3)        |  |  | | Accelerated Online MBA – in Healthcare Management
A MBA with a concentration in Healthcare Management from Marylhurst University can help prepare you for a career in medical research, clinical practice, hospital administration or nonprofit work. Skills that students learn in the program include healthcare marketing, business strategies and management principles. Click here for more information. | |  |  |  |
 - Analysts expect European drugmakers to rebound midyear
Patent expiration for major drugs and reduced government spending loom as obstacles for the European pharmaceutical sector, but analysts at JPMorgan Chase and Deutsche Bank expect growth prospects to improve by midyear. Among factors they considered are increasing developmental pipelines, product launches and restrained spending on mergers and acquisitions. The Wall Street Journal/Health Blog (1/5) - Stem cell study leads to first chimeric primates
Researchers from the Oregon Health and Science University reported that three healthy 4- to 6-month-old monkeys are the first born from a method adapted from one scientists use to create knockout mouse models for research. Early-stage stem cells were combined to make embryos that shared up to six genetic lineages. The study was reported in the journal Cell. USA TODAY (1/5), The Telegraph (London) (1/5) - Layer of stem cells found in back of eye
Researchers discovered central nervous system stem cells in the retinal pigment epithelium layer of the eye. The stem cells appear stable and could have therapeutic uses. They appear unlikely to cause tumors, based on lab and animal tests, researcher Sally Temple said. The discovery could lead to new methods to treat age-related macular degeneration, the main cause of blindness in seniors. Winnipeg Free Press (Manitoba)/The Canadian Press (1/5)  | Active Directory (AD) is the heart of your IT infrastructure, so a solid monitoring and backup and recovery solution is vital! In this Quest tech brief, discover best practices for protecting your AD environment, and how to understand — and resolve — performance problems in record time. |
 - Mediware acquires Transtem to enter stem cell industry
Mediware Information Systems said it has acquired most of the assets of Transtem, a company that develops software for handling the collection and transplantation of adult stem cells for treatment and research. Mediware CEO Thomas Mann said the demand for the use of stem cells is increasing, with stem cells being used in 60,000 procedures in 2009 and with 3,600 stem cell clinical trials under way. American City Business Journals/Kansas City, Mo. (1/4) - Syndexa gets additional funding from MPH
Syndexa Pharmaceuticals has raised $8.5 million more in its Series B1 financing round after securing an investment from MP Healthcare Venture Management. Syndexa will choose a candidate for clinical development from among its endoplasmic reticulum modulating compounds intended for the treatment of metabolic and inflammatory disorders. Mass High Tech (Boston) (1/5)  | Principles of Checkweighing - Building an Effective Program
This essential guide is an invaluable resource of checkweighing information and a definitive reference providing an insight into all aspects of checkweighing from basic principles to implementation of a comprehensive program. Request your free copy now! |
| Food & Agriculture |  |  | | - Judge backs approval of biotech alfalfa
U.S. District Judge Samuel Conti refused to reverse the USDA Animal and Plant Health Inspection Service's decision to completely deregulate Monsanto's glyphosate herbicide-resistant Roundup Ready alfalfa. "None of the purported deficiencies raised by plaintiffs in this area, considered independently or holistically, provide sufficient grounds to set aside APHIS's deregulation determination," Conti said. Capital Press Agriculture Weekly (1/5) | Industrial & Environmental | | | | - BioTork developing method to make biofuels out of papaya
Hawaiian firm BioTork has developed a technology to convert papayas into fatty acids that can be refined into biofuel. The company, in collaboration with Rivertop Solutions and the USDA Pacific Basin Agricultural Research Center, used strains of microorganisms, algae and mushrooms to transform the sugars in papaya waste into oils. Biofuels-News.com (U.K.) (1/5)
| News from BIO | | | | - Ship with FedEx
FedEx is now offering member companies discounts of up to 35% off select FedEx services, both U.S. and international services. The BIO program with FedEx is one of the many cost-savings programs offered by BIO through its Business Solutions program. There is no charge for BIO member companies to participate in any of the BIO Business Solutions programs -- it is a benefit of membership. Learn more about the BIO and FedEx program.
| SmartQuote | | | |  | The best leaders ... almost without exception and at every level, are master users of stories and symbols."
--Tom Peters,
American management expert and writer  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Thursday, January 05, 2012
- Wednesday, January 04, 2012
- Tuesday, January 03, 2012
- Friday, December 30, 2011
- Thursday, December 29, 2011
| | | Lead Editor: Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004 | | | | | | © 1999-2012 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment